Myths & Facts: Plasma Donation
Dispelling the misconceptions about donating plasma could help to shore up the worldwide shortage of this lifesaving blood component used to treat rare and chronic diseases.
Personalized Healthcare
Precise, personal treatment is the way of the future. Here’s how experts are using genetic sequencing to forge a revolutionary new way of practicing medicine.
Myths & Facts: Obsessive-Compulsive Disorder
OCD is no joke, and the rash of hurtful memes about the condition minimize the amount of suffering that people with OCD live through on a daily basis. But perhaps by understanding OCD, how it affects those who suffer from it and how it is treated, the ignorant, albeit mostly innocent, statements such as “I’m so OCD!” will cease.
Psychedelic Medicines: The Future?
Renewed interest and research in psychedelic compounds is giving formerly illicit drugs a 21st century image makeover. Are they really breakthrough solutions for treatment-resistant conditions such as depression and PTSD? At this point, the data looks promising.
Just Arrived: A Trio of Active and Passive Vaccines Against RSV
For decades, respiratory syncytial virus (RSV) has defied the best efforts of vaccine makers to bring it to heel, until now.
Update on Child Hepatitis
An unusual uptick in pediatric hepatitis recently put the medical community on edge. Here’s what we know, why it matters and what to do to mitigate the condition going forward.
The 2022 Childhood Hepatitis Outbreak: What We Know Now
The mystery behind the sudden outbreak of acute severe hepatitis in 2022 is revealed.
Digital Therapeutics: The Next Frontier
This growing field of intervention-based therapeutics promises to enhance patient health and make healthcare more proactive.
How Medical Misinformation About Vaccines is Spread
Politicization and polarization have made finding credible information online harder than ever.
FcRn Antagonists: A Panoply of Autoimmune Disorders Now in the Development Pipeline
Specifically designed to blockade the physiologic IgG recycling function of endothelial cell neonatal crystallizable fragment receptor (FcRn), FcRn antagonists represent a new class of monoclonal antibody-based drugs that have been shown to mediate a sharp, dose-dependent reduction in circulation IgG levels.
